Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: RT who wrote (2416)	11/11/1997 11:26:00 PM
From: BigKNY3	Read Replies (1) \| Respond to of 23519

RT: << I'll bet my last dollar that they were indirectly responsible for several of the articles.>> I am not sure how you can be "indirectly" responsible for an article. Logically it doesn't make any sense for Pfizer to have a PR campaign now. First, it would be illegal. Second, it could jeopardize the current FDA priority review. Third, they can't sell any product, so the effort is useless at this time. The only benefit would be to build up anticipation for an unknown launch date. The risks far outweigh this benefit! Even if a Pfizer manager decided to break the law (which is very, very unlikely), there is no need to position themselves at the current time since it is clear they will be the first oral ED product on the market. A much more likely scenario is the media wanting to focus on to a very hot topic. Sex still sells on both TV and the print media. Accordingly, Pfizer is keeping quiet about Viagra (with the exception of allowable analysts and corporate meetings), getting free PR from a hungry media, and staying within FDA regulations. BigKNY3